Drug Enforcement Administration April 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 38 of 38
Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV
With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration (DEA) places the substance, zopiclone, including its salts, isomers and salts of isomers into Schedule IV of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of Schedule IV will be applicable to the manufacture, distribution, dispensing, importation and exportation of zopiclone and products containing zopiclone.
Electronic Orders for Controlled Substances: Notice of Meeting
The Drug Enforcement Administration (DEA) will hold a public meeting to provide technical details regarding the use of digital signatures and public key infrastructure (PKI) technology within DEA's system for electronic orders for Schedule I and II controlled substances.
Electronic Orders for Controlled Substances
DEA is revising its regulations to provide an electronic equivalent to the DEA official order form, which is legally required for all distributions involving Schedule I and II controlled substances. These regulations will allow, but not require, registrants to order Schedule I and II substances electronically and maintain the records of these orders electronically. The regulations will reduce paperwork and transaction times for DEA registrants who handle, sell, or buy these controlled substances. This rule has no effect on patients' ability to receive prescriptions for controlled substances from practitioners, nor on their ability to have those prescriptions filled at pharmacies.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
